Across randomized experiments and real-call archives, brief audiovisual glitches made communicators feel uncanny and lowered ...
In the first half of 2026, InnoCare made significant progress toward building a leading franchise in hemato-oncology, driven by coordinated advances in commercial execution, late-stage clinical ...
Morning Overview on MSN
The FDA cleared a virus-based therapy for hard-to-treat advanced melanoma
Federal regulators have cleared a genetically engineered virus as a treatment for advanced melanoma that has stopped ...
The Duskbloods is the first FromSoftware game I've immediately disliked ...
InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on cancer and autoimmune diseases, today announced the interim results ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results